{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:03:36Z","timestamp":1793729016639,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003146.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000}}],"reference-count":211,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003146.pub4","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T14:19:34Z","timestamp":1595859574000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease"],"prefix":"10.1002","volume":"2020","author":[{"given":"Lise J","family":"Estcourt","sequence":"additional","affiliation":[{"name":"Haematology\/Transfusion Medicine; NHS Blood and Transplant; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Kohli","sequence":"additional","affiliation":[{"name":"Haematology; Wolfson Institute of Preventive Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"Centre for Statistics in Medicine; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfred C","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology; St Jude Children's Research Hospital; Memphis Tennessee 38105 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"issue":"18","key":"10.1002\/14651858.CD003146.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1182\/blood-2011-06-361642","article-title":"Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease","volume":"120","author":"Bean","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.23877","article-title":"Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy","volume":"90","author":"Beverung","year":"2015","journal-title":"American Journal of Hematology"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/jhg.2011.12","article-title":"Genome-wide association study identifies genetic variants influencing F-cell levels in sickle cell patients","volume":"56","author":"Bhatnagar","year":"2011","journal-title":"Journal of Human Genetics"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/jhg.2011.12","article-title":"Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients","volume":"56","author":"Bhatnagar","year":"2011","journal-title":"Journal of Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08880010903360367","article-title":"Design of the silent cerebral infarct transfusion (SIT) trial","volume":"27","author":"Casella","year":"2010","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Choudhury NA DeBaun MR Ponisio MR Jordan LC Rodeghier M Pruthi S Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities British Journal of Haematology 2018 183 2 324 6 29076125","DOI":"10.1111\/bjh.14979"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0007|cit7","first-page":"E406","article-title":"Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: A report from the silent cerebral infarct transfusion trial","volume":"12","author":"Darbari","year":"2018","journal-title":"American Journal of Hematology"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e27352","DOI":"10.1002\/pbc.27352","article-title":"Children with HbSbeta(0) thalassemia have higher hemoglobin levels and lower incidence rate of acute chest syndrome compared to children with HbSS","volume":"65","author":"Day","year":"2018","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0009|cit9","unstructured":"DeBaun M Epidemiology and treatment of silent strokes in sickle cell anemia 28th Annual Meeting of the National Sickle Cell Disease Program; 2005 Apr 9-13; Cincinnati, Ohio 2005"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD003146.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","article-title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD003146.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpeds.2014.01.001","article-title":"Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction","volume":"164","author":"Dowling","year":"2014","journal-title":"Journal of Pediatrics"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood.V126.23.546.546","article-title":"Progressive loss of brain volume in children with sickle cell anemia: a report from the silent cerebral infarct transfusion trial cohort","volume":"126","author":"Eigbire-Molen","year":"2015","journal-title":"Blood"},{"issue":"16","key":"10.1002\/14651858.CD003146.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood-2018-04-841247","article-title":"Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow","volume":"132","author":"Ford","year":"2018","journal-title":"Blood"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0015|cit15","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.3655.3655","article-title":"Cost-effectiveness of blood transfusions versus observation for silent cerebral infarcts from the silent cerebral infarct trial","volume":"128","author":"Gay","year":"2016","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0016|cit16","unstructured":"Silent cerebral infarct multi-center clinical trial www.isrctn.com\/ISRCTN52713285"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.2009-2800","article-title":"Incidental findings on brain magnetic resonance imaging of children with sickle cell disease","volume":"126","author":"Jordan","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bjh.14039","article-title":"Brain atrophy in paediatric sickle cell anaemia: findings from the silent infarct transfusion (SIT) trial","volume":"177","author":"Kawadler","year":"2017","journal-title":"British Journal of Haematology"},{"issue":"10","key":"10.1002\/14651858.CD003146.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.1002\/ajh.23805","article-title":"Silent cerebral infarction, income, and grade retention among students with sickle cell anemia","volume":"89","author":"King","year":"2014","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0020|cit20","unstructured":"Silent cerebral infarct transfusion multi-center clinical trial (SIT) www.clinicaltrials.gov\/ct2\/show\/NCT00072761"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood.V126.23.3410.3410","article-title":"Parvovirus B19 infection associated with silent cerebral infarcts: a secondary analysis of the silent cerebral infarct trial cohort","volume":"126","author":"Ogunsile","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V116.21.268.268","article-title":"Acute silent cerebral ischemia occurs more frequently than silent cerebral infarction in children with sickle cell anemia","volume":"116","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD003146.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/pbc.25072","article-title":"Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemia","volume":"61","author":"Roberts","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10278-008-9114-3","article-title":"Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain","volume":"22","author":"Vendt","year":"2009","journal-title":"Journal of Digital Imaging"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ajh.23854","article-title":"Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort","volume":"90","author":"Wolf","year":"2015","journal-title":"American Journal of Hematology"},{"issue":"19","key":"10.1002\/14651858.CD003146.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMc1411133","article-title":"Transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"Land","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0027|cit27","first-page":"645a","article-title":"Magnetic resonance angiography (MRA) in children with abnormal transcranial doppler (TCD) velocities in the STOP study","volume":"94","author":"Abboud","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0028|cit28","unstructured":"Abboud MR Cure J Gallagher D Berman B Hsu L Wang W Magnetic resonance angiography in children with abnormal TCD in the STOP study 23rd Annual Meeting of the National Sickle Cell Disease Program 1999 49"},{"issue":"7","key":"10.1002\/14651858.CD003146.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood-2003-06-1972","article-title":"Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study","volume":"103","author":"Abboud","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0030|cit30","unstructured":"Adamkiewicz T Abboud M Barredo J Cavalier ME Peterson J Rackoff B Serum Ferritin in children with SCD on chronic transfusion: correlation with serum alanine aminotransferase and liver iron (STOP\/STOP II liver iron ancillary study) 35th Anniversary Convention of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America; 2007 Sep 17-22; Washington DC, USA 2007 316"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Adamkiewicz T Abboud MR Barredo JC Kirby-Allen M Alvarez OA Casella JF Serum ferritin in children with sickle cell disease on chronic transfusion: measure of iron overload or end organ injury? STOP\/ STOP II liver iron ancillary study Blood 2006","DOI":"10.1182\/blood.V108.11.791.791"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","article-title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","volume":"114","author":"Adamkiewicz","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0033|cit33","unstructured":"Adams R Brambilla D Clinical alert: periodic transfusions lower stroke risk in children with sickle cell anemia www.nlm.nih.gov\/databases\/alerts\/sickle97.html 2000 Accessed 20 January 2020"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0034|cit34","article-title":"Development of high risk TCD in sickle cell disease","volume":"46","author":"Adams","year":"2015","journal-title":"Stroke"},{"issue":"10","key":"10.1002\/14651858.CD003146.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0036|cit36","first-page":"419a","article-title":"Risk of stroke in children with sickle cell disease and abnormal transcranial doppler ultrasound (TCD)","volume":"94","author":"Adams","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0037|cit37","unstructured":"Adams RJ Brambilla DJ McKie V Files B Vichinsky E Abboud M Stroke prevention in sickle cell disease (STOP): Baseline characteristics of trial patients 22nd Annual Meeting of the National Sickle Cell Disease Program 1997 41"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD003146.pub4-BIB0038|cit38","first-page":"10a","article-title":"Stroke prevention in sickle cell disease (STOP): final results","volume":"96","author":"Adams","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0039|cit39","unstructured":"Adams RJ Brambilla DJ McKie V Files B Vichinsky E Abboud M Stroke prevention in sickle cell disease (STOP): final results 25th Annual Meeting of the National Sickle Cell Disease Program 2001"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0040|cit40","first-page":"527a","article-title":"Stroke prevention in sickle cell disease (STOP): follow-up after closure of the trial","volume":"92","author":"Adams","year":"1998","journal-title":"Blood"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0041|cit41","first-page":"123a","article-title":"Stroke prevention in sickle cell disease (STOP): baseline characteristics of trial patients","volume":"90","author":"Adams","year":"1997","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0042|cit42","unstructured":"Adams RJ Brambilla DJ Vichinsky E Abboud M Pegelow C Carl EM Risk of stroke and conversion to abnormal TCD in children screened with transcranial doppler (TCD) during the STOP study National Sickle Cell Disease Program 30th Annual Meeting; 2002 Sept 17-21 2002 3"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0043|cit43","unstructured":"Adams RJ Brambilla DJ Vichinsky E Abboud M Pegelow C Carl EM Stroke prevention trial in sickle cell anemia (STOP study): Risk of stroke in 1933 children screened with transcranial doppler (TCD) 23rd Annual Meeting of the National Sickle Cell Disease Program 1999 54"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0044|cit44","unstructured":"Adams RJ Brambilla DJ Stroke prevention trial in sickle cell anemia: STOP 21st Annual Meeting of the National Sickle Cell Disease Program 1996 19"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0045|cit45","unstructured":"Adams RJ Carl EM McKie VC Odo NA Kutlar A Phillips M A pilot trial of hydroxyurea to prevent strokes in children with sickle cell anemia 23rd Annual Meeting of the National Sickle Cell Disease Program 1999 53"},{"issue":"12","key":"10.1002\/14651858.CD003146.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/ajh.24551","article-title":"Transcranial Doppler Re-screening of Subjects who Participated in STOP and STOP","volume":"91","author":"Adams","year":"2016","journal-title":"American Journal of Hematology"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0047|cit47","first-page":"308","article-title":"Stroke prevention in sickle cell disease (STOP): Results of transcranial doppler ultrasound screening stroke risk","volume":"29","author":"Adams","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0050|cit50","unstructured":"Adams RJ McKie VC Hsu L Periodic blood transfusions reduced the risk for stroke in children with sickle-cell anaemia Evidence-based Medicine 1999 4 2 54"},{"issue":"5","key":"10.1002\/14651858.CD003146.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.10776","article-title":"Sickle cell disease and stroke: primary prevention and transcranial Doppler","volume":"54","author":"Adams","year":"2003","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003146.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","article-title":"Lessons from the stroke prevention trial in sickle cell anemia (STOP) study","volume":"15","author":"Adams","year":"2000","journal-title":"Journal of Child Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003146.pub4-BIB0053|cit53","first-page":"363","article-title":"Transfusion to prevent first stroke in children with sickle cell anemia","volume":"98","year":"1998","journal-title":"Journal of the American Ostoepathic Association"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s002470000317","article-title":"Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation","volume":"30","author":"Bulas","year":"2000","journal-title":"Pediatric Radiology"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJM199807023390109","article-title":"Sickle cell disease - new treatments, new questions","volume":"339","author":"Cohen","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003146.pub4-BIB0056|cit56","first-page":"498","article-title":"Ischemic stroke in sickle cell disease: a review","volume":"90","author":"Duncan","year":"1997","journal-title":"Tennessee Medicine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0057|cit57","first-page":"528a","article-title":"A randomized trial of chronic transfusion to prevent stroke in sickle cell anemia: changes in ferritin with chronic transfusion","volume":"92","author":"Files","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00043426-200205000-00013","article-title":"Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)","volume":"24","author":"Files","year":"2002","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003146.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1067\/mpd.2002.128754","article-title":"Stroke prevention trial in sickle cell anemia: comments on effects of chronic transfusion on pain","volume":"141","author":"Gates","year":"2002","journal-title":"Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD003146.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"Alpha thalassemia is associated with decreased risk of abnormal transcranial doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"Hsu","year":"2003","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"8","key":"10.1002\/14651858.CD003146.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e0134193","DOI":"10.1371\/journal.pone.0134193","article-title":"Effect of chronic blood transfusion on biomarkers of coagulation activation and thrombin generation in sickle cell patients at risk for stroke","volume":"10","author":"Hyacinth","year":"2015","journal-title":"Plos One"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Hyacinth HI Adams RJ Voeks JH Hibbert JM Gee BE Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk American Journal of Hematology 2014 89 1 47 51 23996496","DOI":"10.1002\/ajh.23586"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0063|cit63","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.244.244","article-title":"High frequency of RBC transfusions in the STOP study was associated with reduction in serum biomarkers of neurodegeneration, vascular remodeling and inflammation","volume":"120","author":"Hyacinth","year":"2012","journal-title":"Blood"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood.V126.23.3402.3402","article-title":"Impact of TCD screening protocol on the incidence of hemorrhagic stroke in children and young adults with sickle cell disease","volume":"126","author":"Kanter","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0065|cit65","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.429.429","article-title":"Candidate gene polymorphisms and their association with TCD velocities in children with sickle cell disease","volume":"110","author":"Kutlar","year":"2007","journal-title":"Blood"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD003146.pub4-BIB0066|cit66","first-page":"18b","article-title":"Laboratory parameters in patients randomized in the STOP study and their modification by transfusion","volume":"96","author":"Kutlar","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0067|cit67","unstructured":"Kutlar A Harbin J Jackson BB Holley LGD Clair B Brambilla D Baseline laboratory parameters in patients randomized to the STOP study and their modification by transfusion 24th Annual Meeting of the National Sickle Cell Disease Program 2000 82a"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0068|cit68","article-title":"Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease","volume":"102","author":"Kwiatkowski","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2141.2006.06193.x","article-title":"Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial","volume":"134","author":"Kwiatkowski","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood.V126.23.68.68","article-title":"Ischemic stroke in children and young adults with sickle cell disease (SCD) in the post-stop era","volume":"126","author":"Kwiatkowski","year":"2015","journal-title":"Blood"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD003146.pub4-BIB0071|cit71","first-page":"663a","article-title":"Long-term follow-up of transcranial doppler ultrasonography in children with sickle cell disease: Results of the STOP and STOP II patient cohorts","volume":"100","author":"Kwiatkowski","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results","volume":"108","author":"Lee","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0073|cit73","first-page":"373","article-title":"C-reactive protein in children with sickle cell disease at risk for stroke in the STOP study","volume":"33","author":"Lee","year":"2002","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.STR.0000221173.97108.01","article-title":"Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke","volume":"37","author":"Lezcano","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0075|cit75","first-page":"695","article-title":"Transfusion lowers plasma-free hemoglobin in children with sickle cell disease at risk for stroke","volume":"37","author":"Lezcano","year":"2006","journal-title":"Stroke"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003146.pub4-BIB0076|cit76","first-page":"251A","article-title":"Impact of chronic transfusion on non-neurological events during the Stroke Prevention Trial in sickle cell anemia (STOP)","volume":"47","author":"Miller","year":"2000","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0077|cit77","unstructured":"Miller ST Wright E Abboud M Berman B Files B Scher C Impact of chronic transfusion on non-neurological events during the stroke prevention trial in sickle cell anemia (TOP) 24th Annual Meeting of the National Sickle Cell Disease Program 2000 61a"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0079|cit79","unstructured":"Stroke Prevention in Sickle Cell Anemia (STOP 1) www.clinicaltrials.gov\/show\/nct00000592"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1552-6569.2001.tb00063.x","article-title":"Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing","volume":"11","author":"Nichols","year":"2001","journal-title":"Journal of Neuroimaging"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD003146.pub4-BIB0081|cit81","first-page":"486a","article-title":"Changes in cerebral blood flow velocities during chronic transfusion therapy to prevent stroke in sickle cell disease","volume":"96","author":"Olivieri","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0082|cit82","unstructured":"Pegelow CH Adams R Hsu L McKie V Wang W Zimmerman R Children with silent infarct and elevated transcranial doppler ultrasonography velocity are at increased risk of subsequent infarctive events 23rd Annual Meeting of the National Sickle Cell Disease Program 1999 137"},{"issue":"12","key":"10.1002\/14651858.CD003146.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1001\/archneur.58.12.2017","article-title":"Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity","volume":"58","author":"Pegelow","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJM199811123392013","article-title":"Prevention of stroke by transfusions in children with sickle cell anemia","volume":"339","author":"Sarnaik","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0085|cit85","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.3219.3219","article-title":"Long term outcome of patients enrolled into STOP and STOP II trials: a single center experience","volume":"120","author":"Sayer","year":"2012","journal-title":"Blood"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0086|cit86","first-page":"604a","article-title":"Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening","volume":"90","author":"Styles","year":"1997","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0087|cit87","unstructured":"Vichinsky E Luban E Wright E Olivieri N Driscoll C Pegelow C Prospective red cell phenotype matching in STOP - a multi-centre transfusion trial 23rd Annual Meeting of the National Sickle Cell Disease Program 1999 163"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0088|cit88","first-page":"528a","article-title":"Prospective red cell phenotype matching in STOP - a multi-center transfusion trial","volume":"92","author":"Vichinsky","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD003146.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0090|cit90","unstructured":"Wang W Morales K Olivieri N Styles L Scher C Adams R Effect of chronic transfusion on growth in children with sickle cell anemia: results of the STOP trial National Sickle Cell Disease Program 30th Annual Meeting Conference; 2002 Sept 17-21 2002 100"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2005.02.030","article-title":"Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial","volume":"147","author":"Wang","year":"2005","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0092|cit92","unstructured":"NHLBI stops the STOP II trial early www.hematology.org\/publications\/newsdaily\/2004\/issue_3\/NHLBI.cfm"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0093|cit93","article-title":"The progression and development of silent infarcts in children with sickle cell anemia is prevented by chronic transfusions and is unrelated to level of hemolysis","volume":"12","author":"Abboud","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2010-12-326298","article-title":"Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II","volume":"118","author":"Abboud","year":"2011","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0095|cit95","unstructured":"Adamkiewicz T Abboud M Barredo J Cavalier ME Peterson J Rackoff B Serum Ferritin in children with SCD on chronic transfusion: correlation with serum alanine aminotransferase and liver iron (STOP\/STOP II liver iron ancillary study) 35th Anniversary Convention of the National Sickle Celll Disesae Program and the Sickle Cell Disease Association of America; 2007 Sep 17-22; Washington DC, USA 2007 316"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0096|cit96","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.791.791","article-title":"Serum ferritin in children with sickle cell disease on chronic transfusion: measure of iron overload or end organ injury? STOP\/ STOP II liver iron ancillary study","volume":"108","author":"Adamkiewicz","year":"2006","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0097|cit97","unstructured":"Adamkiewicz T Transcranial doppler measures in patients with sickle cell disease at high risk for stroke and receiving hydroxyurea: the HyRetro ancillary study 52nd ASH Annual Meeting and Exposition; 2010 Dec 4-7; Orlando, Florida 2010"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","article-title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","volume":"114","author":"Adamkiewicz","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0099|cit99","unstructured":"Adams RJ Brambilla D Miller ST Optimizing primary stroke prevention in children with sickle cell 28th Annual Meeting of the National Sickle Cell Disease Program; 2005 April 9-13; Cincinnati, Ohio 2005 3"},{"issue":"26","key":"10.1002\/14651858.CD003146.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0101|cit101","unstructured":"Adams RJ Brambilla DJ STOP II investigators The study design of optimizing primary stroke prevention in children with sickle cell anemia 27th Annual Meeting of the National Sickle Cell Disease Program; 2004 April 18-21; Los Angeles, California 2004 174"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0102|cit102","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.3732.3732","article-title":"Evaluation of chronic transfusion practices in children with sickle cell disease: a survey of STOP II investigators","volume":"104","author":"Alvarez","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0103|cit103","unstructured":"Brambilla DJ Adams RJ Stroke prevention in sickle cell anemia (STOP 2) National Institutes of Health, Clinical Trials Database"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0104|cit104","unstructured":"Brown C Miller S Kwiatkowski J Brambilla D Adams R Optimizing primary stroke prevention in sickle cell anemia (STOP 2): an argument for prolonged transfusion? 29th Annual Meeting of the National Sickle Cell Disease Program; 2006 April 8-12; Memphis, USA 2006 78"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood.V126.23.3402.3402","article-title":"Impact of TCD screening protocol on the incidence of hemorrhagic stroke in children and young adults with sickle cell disease","volume":"126","author":"Kanter","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0106|cit106","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.429.429","article-title":"Candidate gene polymorphisms and their association with TCD velocities in children with sickle cell disease","volume":"110","author":"Kutlar","year":"2007","journal-title":"Blood"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood.V126.23.68.68","article-title":"Ischemic stroke in children and young adults with sickle cell disease (SCD) in the post-stop era","volume":"126","author":"Kwiatkowski","year":"2015","journal-title":"Blood"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD003146.pub4-BIB0108|cit108","first-page":"663a","article-title":"Long-term follow-up of transcranial doppler ultrasonography in children with sickle cell disease: results of the STOP and STOP II patient cohorts","volume":"100","author":"Kwiatkowski","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0109|cit109","unstructured":"Medical College of Georgia STOP II Questions and Answers www.mcg.edu\/neurology\/Research\/sicklecell\/STOPIIQandA.htm"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0110|cit110","unstructured":"Medical News Today NHLBI stops sickle cell anemia transfusion study www.medicalnewstoday.com\/printerfriendlynews.php?newsid=17363"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0111|cit111","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.3219.3219","article-title":"Long term outcome of patients enrolled into STOP and STOP II trials: a single center experience","volume":"120","author":"Sayer","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ajh.23547","article-title":"Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial","volume":"88","author":"Alvarez","year":"2013","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0113|cit113","unstructured":"Stroke prevention study in children with sickle cell anemia, iron overload stopped early www.nih.gov\/news\/health\/jun2010\/nhlbi-03.htm 2010 Accessed 20 January 2020"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bjh.13280","article-title":"Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload","volume":"169","author":"Aygun","year":"2015","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0115|cit115","unstructured":"Aygun B Mortier NA Kesler K Schultz WH Alvarez OA Rogers ZR Therapeutice phlebotomy in children with sickle cell anemia, stroke, and iron overload: the SWiTCH experience 53rd ASH Annual Meeting and Exposition; 2011 Dec 10-13; San Diego, California 2011"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.22228","article-title":"Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention","volume":"87","author":"Kwiatkowski","year":"2012","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0118|cit118","unstructured":"Stroke with transfusions changing to hydroxyurea (SWiTCH) www.clinicaltrials.gov\/show\/NCT00122980"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0119|cit119","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.241.241","article-title":"Genetic predictors of hemoglobin F response to hydroxyurea in sickle cell anemia","volume":"120","author":"Sheehan","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1002\/14651858.CD003146.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Ware RE Helms RW Stroke with transfusions changing to hydroxyurea (SWiTCH): a phase 3 randomised clinical trial for treatment of children with sickle cell anemia 52nd ASH Meeting and Exposition; 2010 Dec 4-7; Orlando, Florida 2010","DOI":"10.1182\/blood.V116.21.844.844"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0122|cit122","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.1213.1213","article-title":"Academic community standards for chronic transfusion therapy in children with sickle cell anemia and stroke","volume":"108","author":"Ware","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/pbc.23145","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload","volume":"57","author":"Ware","year":"2011","journal-title":"Pediatric Blood & Cancer"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0124|cit124","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1018.1018","article-title":"Iron unloading by therapeutic phlebotomy in previously transfused children with sickle cell anemia: the twitch experience","volume":"128","author":"Aygun","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.23105","article-title":"Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities","volume":"87","author":"Aygun","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0126|cit126","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.2494.2494","article-title":"Assessment of hematological data in a cohort of european children with sickle cell anemia treated with hydroxyurea: can European centers apply today the lessons from the twitch study?","volume":"128","author":"De Montalembert","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood.V124.21.4052.4052","article-title":"Effects of chronic transfusion therapy on MRI and MRA in children with sickle cell anemia at risk for primary stroke: baseline imaging from the Twitch Trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/blood.V124.21.87.87","article-title":"Effects of chronic transfusion therapy on transcranial doppler ultrasonography velocities in children with sickle cell anemia at risk for primary stroke: Baseline findings from the twitch trial","volume":"124","author":"Imran","year":"2014","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0129|cit129","unstructured":"Transcranial doppler (TCD) with transfusions changing to hydroxyurea (TWiTCH) www.clinicaltrials.gov\/ct2\/show\/NCT01425307"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V126.23.3.3","article-title":"TCD with transfusions changing to hydroxyurea (TWITCH): Hydroxyurea therapy as an alternative to transfusions for primary stroke prevention in children with sickle cell anemia","volume":"126","author":"Ware","year":"2015","journal-title":"Blood"},{"issue":"10019","key":"10.1002\/14651858.CD003146.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood.V128.22.1019.1019","article-title":"Variation in serial TCD velocity measurements in the TCD with transfusions changing to hydroxyurea (TWiTCH) trial","volume":"128","author":"Ware","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD003146.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V122.21.2238.2238","article-title":"Extrahepatic iron deposition in chronically transfused children with sickle cell anemia - Baseline findings from the twitch trial","volume":"122","author":"Wood","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bjh.13791","article-title":"Organ iron accumulation in chronically transfused children with sickle cell anaemia: Baseline results from the TWiTCH trial","volume":"172","author":"Wood","year":"2016","journal-title":"British Journal of Haematology"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0135|cit135","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.202.202","article-title":"Changes in extrahepatic iron load in response to iron chelation versus phlebotomy: observations from the twitch trial","volume":"128","author":"Wood","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD003146.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24089","article-title":"Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: Baseline results from the TWiTCH trial","volume":"90","author":"Wood","year":"2015","journal-title":"American Journal of Hematology"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0137|cit137","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1274.1274","article-title":"Agreement between R2 and R2* liver iron estimates is independent of the type of iron removal therapy: results from the twitch trial","volume":"128","author":"Wood","year":"2016","journal-title":"Blood"},{"issue":"10048","key":"10.1002\/14651858.CD003146.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(16)31492-1","article-title":"Treating sickle cell anaemia: the TWiTCH trial","volume":"388","author":"Bernaudin","year":"2016","journal-title":"Lancet"},{"issue":"S1","key":"10.1002\/14651858.CD003146.pub4-BIB0139|cit139","first-page":"617","article-title":"Health-related quality of life at 1 year in the drepagreffe trial comparing chronic transfusion to transplantation in children with sickle cell anemia and a history of abnormal cerebral velocities","volume":"130","author":"Bernaudin","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0140|cit140","first-page":"S49","article-title":"Trial comparing HSCT vs transfusions in sickle cell anemia (SCA)-patients with abnormal cerebral velocities: cerebral vasculopathy outcome at 1 year","volume":"51","author":"Bernaudin","year":"2017","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0141|cit141","first-page":"168","article-title":"Children with sickle cell anemia on chronic transfusion for abnormal transcranial doppler velocities. Patient\/ sibling comparison of cognitive performances and association with neuroimaging data","volume":"101","author":"Bernaudin","year":"2016","journal-title":"Haematologica"},{"issue":"23","key":"10.1002\/14651858.CD003146.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood.V126.23.544.544","article-title":"French national drepagreffe trial: Cognitive performances and neuroimaging at enrollment and after 12 months on transfusion program or transplantation (AP-HP: NCT 01340404)","volume":"126","author":"Bernaudin","year":"2015","journal-title":"Blood"},{"issue":"S1","key":"10.1002\/14651858.CD003146.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/blood-2018-99-118091","article-title":"Probability of TCD-Normalization in the \"Drepagreffe\" Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels","volume":"132","author":"Bernaudin","year":"2018","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cct.2017.08.008","article-title":"Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404)","volume":"62","author":"Chevret","year":"2017","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0145|cit145","first-page":"S24","article-title":"Transcranial doppler ultrasonography (TCD), organ function, metabolic and nutritional status in children with sickle cell anemia: baseline data from the EXTEND trial","volume":"64","author":"Rankine-Mullings","year":"2017","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.2196\/resprot.5872","article-title":"EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia","volume":"5","author":"Rankine-Mullings","year":"2016","journal-title":"JMIR Research Protocols"},{"issue":"10048","key":"10.1002\/14651858.CD003146.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(16)31493-3","article-title":"Treating sickle cell anaemia: the TWiTCH trial","volume":"388","author":"Gwam","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.2196\/resprot.7491","article-title":"Stroke Avoidance for Children in REpublica Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia","volume":"6","author":"Jeste","year":"2017","journal-title":"JMIR Research Protocols"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003146.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1182\/bloodadvances.2018GS110818","article-title":"Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial","volume":"2","author":"Sanchez","year":"2018","journal-title":"Blood Advances"},{"issue":"12","key":"10.1002\/14651858.CD003146.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ajh.24198","article-title":"Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial","volume":"90","author":"Hankins","year":"2015","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0151|cit151","unstructured":"Sparing conversion to abnormal TCD (transcranial doppler) elevation (SCATE) www.clinicaltrials.gov\/show\/NCT01531387"},{"issue":"22","key":"10.1002\/14651858.CD003146.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood.V128.22.122.122","article-title":"Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)","volume":"128","author":"Galadanci","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD003146.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.24770","article-title":"Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)","volume":"92","author":"Galadanci","year":"2017","journal-title":"American Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1002\/ajh.25012","article-title":"Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)","volume":"93","author":"Galadanci","year":"2018","journal-title":"American Journal of Hematology"},{"issue":"8","key":"10.1002\/14651858.CD003146.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.STR.23.8.1073","article-title":"Transcranial Doppler correlation with cerebral angiography in sickle cell disease","volume":"23","author":"Adams","year":"1992","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"e2013062","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2009.07630.x","article-title":"Chronic transfusion practice for children with sickle cell anaemia and stroke","volume":"145","author":"Aygun","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD003146.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V79.7.1657.1657","article-title":"A modified program for prevention of stroke in sickle cell disease","volume":"79","author":"Cohen","year":"1992","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0163|cit163","first-page":"39","volume-title":"New Directions in Pediatric Hematology","author":"Cohen","year":"1996"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0164|cit164","unstructured":"Covidence systematic review software Veritas Health Innovation 2015"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/mrdd.20118","article-title":"Etiology of strokes in children with sickle cell anemia","volume":"12","author":"DeBaun","year":"2006","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0166|cit166","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2010.03.007","article-title":"Transcranial doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease","volume":"157","author":"Enninful-Eghan","year":"2010","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD003146.pub4-BIB0168|cit168","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012389","article-title":"Interventions for preventing silent cerebral infarcts in people with sickle cell disease","author":"Estcourt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2004-02-0636","article-title":"Declining stroke rates in Californian children with sickle cell disease","volume":"104","author":"Fullerton","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/515S1a","article-title":"Sickle-cell disease","volume":"515","author":"Gravitz","year":"2014","journal-title":"Nature"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa. A neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood-2014-10-605964","article-title":"Higher-than-expected prevalence of silent cerebral infarcts in children with hemoglobin SC disease","volume":"125","author":"Guilliams","year":"2015","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0173|cit173","unstructured":"Higgins JP Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editors(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0174|cit174","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0175|cit175","unstructured":"Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pbc.22721","article-title":"Iron in sickle-cell disease: what have we learned over the years?","volume":"56","author":"Inati","year":"2011","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1542\/peds.103.3.640","article-title":"Silent cerebral infarcts in sickle cell anemia: a risk factor analysis","volume":"103","author":"Kinney","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2141.2009.07753.x","article-title":"Silent infarcts in young children with sickle cell disease","volume":"146","author":"Kwiatkowski","year":"2009","journal-title":"British Journal of Haemtology"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results","volume":"108","author":"Lee","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.21430","article-title":"Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia","volume":"50","author":"McCarville","year":"2008","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0268-960X(03)00003-1","article-title":"The paradox of hemoglobin SC disease","volume":"17","author":"Nagel","year":"2003","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0182|cit182","unstructured":"(NICE) National Institute for Health and Care Excellence Sickle cell disease 2010 cks.nice.org.uk\/sickle-cell-disease#!backgroundsub:3"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0183|cit183","unstructured":"Ohene-Frempong K Sickle cell disease in the United States of America and Africa Hematology (American Society of Hematology Education Program) American Society of Hematology 1999 64 72"},{"issue":"6","key":"10.1002\/14651858.CD003146.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"9861","key":"10.1002\/14651858.CD003146.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2012","journal-title":"Lancet"},{"issue":"7526","key":"10.1002\/14651858.CD003146.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1002\/14651858.CD003146.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1365-2141.2000.01912.x","article-title":"Management of cerebral vasculopathy in children with sickle cell anaemia","volume":"108","author":"Powars","year":"2000","journal-title":"British Journal of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD003146.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(97)70108-2","article-title":"Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke","volume":"131","author":"Rana","year":"1997","journal-title":"Journal of Pediatrics"},{"issue":"9757","key":"10.1002\/14651858.CD003146.pub4-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0190|cit190","unstructured":"Review Manager (RevMan) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"e100516","DOI":"10.1371\/journal.pone.0100516","article-title":"The co-inheritance of alpha-thalassemia and sickle cell anemia Is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival","volume":"9","author":"Rumaney","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1002\/14651858.CD003146.pub4-BIB0192|cit192","first-page":"1254","article-title":"Periodic transfusions for sickle cell anemia and CNS infarction","volume":"133","author":"Sarnaik","year":"1979","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0193|cit193","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0194|cit194","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0195|cit195","first-page":"48","article-title":"Risk of\u00a0recurrent\u00a0stroke\u00a0in\u00a0children\u00a0with\u00a0sickle cell disease\u00a0receiving\u00a0blood transfusion\u00a0therapy for at least five years after initial\u00a0stroke","volume":"140","author":"Scothorn","year":"2002","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0196|cit196","first-page":"455","volume-title":"Sickle Cell Disease","author":"Serjeant","year":"1992"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pbc.24179","article-title":"Indications and complications of transfusions in sickle cell disease","volume":"59","author":"Smith-Whitley","year":"2012","journal-title":"Pediatric Blood & Cancer"},{"issue":"13","key":"10.1002\/14651858.CD003146.pub4-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003146.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003146.pub4-BIB0200|cit200","unstructured":"Sterne JA Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD003146.pub4-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3476(05)82006-2","article-title":"Effects of a long-term transfusion regimen on sickle cell-related illnesses","volume":"125","author":"Styles","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD003146.pub4-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.25.11.2153","article-title":"Middle cerebral artery velocity changes during transfusion in sickle cell anemia","volume":"25","author":"Venketasubramanian","year":"1994","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease","volume":"118","author":"Wang","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2005.02.030","article-title":"Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial","volume":"147","author":"Wang","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003146.pub4-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpeds.2004.04.058","article-title":"Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy","volume":"145","author":"Ware","year":"2004","journal-title":"Journal of Pediatrics"},{"issue":"26","key":"10.1002\/14651858.CD003146.pub4-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD003146.pub4-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-3476(80)80803-1","article-title":"Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents","volume":"96","author":"Wilimas","year":"1980","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0209|cit209","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146.pub3","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","author":"Estcourt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003146.pub4-BIB0210|cit210","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146","article-title":"Blood transfusion for preventing stroke in people with sickle cell disease","author":"Hirst","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003146.pub4-BIB0211|cit211","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146.pub2","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","author":"Wang","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T03:43:52Z","timestamp":1728272632000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003146.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":211,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003146.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]}}}